MLB playoff games on TV today: Schedule, times, TV channels, live streams to watch ALCS, NLCS games originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
The 2026 World Series could be set Monday night, with the Rays on the brink of advancing as they host Game 6 against the Guardians.
Tampa Bay's 3-1 win Sunday put Cleveland on the brink, needing a pair of wins at Tropicana Field to return to the Fall Classic for the first time since 2016. The Rays are trying to reach the World Series for the third time, but their most recent trip came in the COVID-shortened 2020 season when all the games were played in Arlington, Texas, so their fans mostly missed out that time.
The Rays got a brilliant pitching performance from Drew Rasmussen in Game 5 and will look for more of the same Monday with veteran Freddy Peralta on the mound. The trade-deadline acquisition started Game 2 of this series and was dominant, holding the Guardians to four hits in six scoreless innings of a 3-1 Tampa Bay win. He also pitched 2/3 of an inning in relief Saturday in Game 4.
Cleveland's pitching situation is unclear but it will be all hands on deck for Stephen Vogt as the Guardians hope their offense can get going the way it did to turn around the Division Series against the White Sox. Can they stay alive, or will the top-seeded Rays move on?

#Guardians #sporting #World

Pfizer (NYSE: PFE) is offering a dividend yield of roughly 6% today. That is well above the roughly 1% yield on offer from the S&P 500 index (SNPINDEX: ^GSPC) and the 1.4% average yield of pharmaceutical stocks. There are good reasons for the negative view of Pfizer, but investors may be ignoring the company's over 100-year history of success. Here's why you may want to consider buying this out-of-favor dividend stock while others are fearful.
Pfizer's stock rocketed higher during the coronavirus pandemic, as investors myopically focused on the company's COVID vaccine. When COVID turned out to be a less serious long-term threat than originally believed, Wall Street dumped Pfizer. At this point, the stock is down more than 50% from its 2021 high. That is a big part of the story behind the high yield.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
However, there's another piece that is more fundamental to the pharmaceutical industry. Like all drug makers, Pfizer's drugs receive time-limited patent protections. When patents expire, generic versions of the medications can be produced. That generally leads to a dramatic decline in revenue from Pfizer's drugs. Right now, Pfizer is facing down some notable patent expirations. This is a completely normal dynamic in the pharmaceutical sector.
Patent expirations are why drug companies are always on the lookout for new drugs. The problem is that patent expirations follow a set schedule, but drug development does not. Pfizer's drug pipeline isn't producing major new drugs right now, and it looks like it may have to work through a period in which new drugs won't fully offset revenue lost to patent expirations. This isn't uncommon, either, but investors are likely focusing on the short term rather than the long term when it comes to Pfizer.

#patent #yield #drug #expirations

Khaby Lame turned a simple comedy concept into a global creator business. The Senegalese-born Italian star built his following by silently mocking complicated life-hack videos. His signature facial expressions and palms-up gesture became instantly recognizable. Lame has more than 160 million TikTok followers and was ranked among the world's highest-earning creators in 2025. Forbes estimated his earnings at $20 million that year. But what is Khaby Lame's net worth?
Lame's rise started after he lost his factory job during Italy's COVID-19 lockdown in 2020. TikTok gave him an audience, but brand partnerships turned that attention into money. Forbes Africa further reports that Lame has worked with brands including Hugo Boss, Airbnb and Binance. His business now stretches beyond TikTok, making Khaby Lame's net worth a bigger creator-economy story.
Yes, but the $975 million headline needs context. In January 2026, Rich Sparkle Holdings announced its acquisition of Step Distinctive Limited, a company tied to Lame's brand. According to Forbes Africa, Lame owned 49% of Step Distinctive before the transaction.
The deal involved Rich Sparkle shares rather than a straightforward cash payment. Forbes Africa also reported that Lame's stake reached a paper value of $6.6 billion when Rich Sparkle's stock surged.
That figure did not mean Lame suddenly had $6.6 billion in cash. Forbes also raised concerns about Rich Sparkle's small public float and the difficulty of using its stock price to measure Lame's actual wealth.

#rich #million #distinctive

Doctors discuss COVID, flu and RSV vaccines recommended this year.
As the weather turns colder, it also means respiratory virus season is upon the United States.
In its annual outlook report, the Centers for Disease Control and Prevention (CDC) said it expects the 2026-27 respiratory virus season to have a similar number of peak hospitalizations from influenza, COVID-19 and RSV compared to last season.
Public health specialists told ABC News the best way for people to protect themselves against these viruses is to get vaccinated.
Flu vaccine

#season #virus #centers

Karl-Anthony Towns says the pandemic brought him closer to Jordyn Woods, deepening a friendship that eventually became a marriage.
The New York Knicks center told PEOPLE that having COVID-19 "broke me down to the core," while also helping shape the man he became.
He said Woods witnessed his illness firsthand and understands why he remains particularly protective of himself and his family when it comes to the virus.
The interview comes as Towns serves as a paid spokesperson for Sanofi in a campaign promoting NUVAXOVID, a protein-based COVID-19 vaccine. Sanofi announced the partnership on Oct. 2.
Towns' mother, Jacqueline Cruz-Towns, died on April 13, 2020, at 58 after spending about a month hospitalized with COVID-19. His father, Karl Towns Sr., also contracted the virus and recovered. Other relatives died as the pandemic continued.

#towns #covid #virus #died

Amanda Seyfried shared a clip of herself on Instagram singing Joni Mitchell's "A Case of You" while playing the dulcimer when her daughter Nina, 9, appeared behind her in a Scream Ghost Face mask
The Housemaid star screamed and stopped recording after spotting the masked figure on her phone screen
Seyfried learned the dulcimer during the COVID-19 pandemic and previously performed Joni Mitchell on The Tonight Show with host Jimmy Fallon
Amanda Seyfried's 9-year-old daughter Nina is gearing up for spooky season early!
On Tuesday, Oct. 6, The Housemaid star, 40, shared an Instagram Reel of herself strumming the dulcimer and singing the Joni Mitchell track, "A Case of You."

#amanda #seyfried #case #mitchell

Chelsy Davy has revealed she never "wanted" marriage or motherhood until she met her husband, Sam Cutmore-Scott.
The entrepreneur, who dated Prince Harry on-off for seven years until 2011, shared a rare personal essay on Tuesday to celebrate ten years since founding her Aya Jewels line.
Chelsy, who turns 41 next week, recalled how she met her husband during Covid, aged 35, after years of whirlwind travel when "the only thing I was committed to was having fun".
The couple now has three children, Leo, four, Chloe, three, and Finn, six months, and has settled down in Mauritius.
Chelsy and Sam Cutmore-Scott married in a secret ceremony in 2022 (@ Instagram)

#cutmore #until #davy #harry

The US economy is stacking up wins, even if it doesn't feel that way for many households because of the resurgence in inflation.
The economy has now posted 78 consecutive months of expansion, the sixth-longest business cycle since 1854, per new ***** ysis from The Kobeissi Letter. This is well above the long-term average of 49 months and the median of 38 months.

By comparison, the longest period for the US economy without a recession was between 2009 and 2020, at 128 months. The record of course was broken by the aftershocks of the COVID-19 pandemic, which ground the economy to a halt.
Read more: Scaramucci: Lots of Americans 'feel left out of the system'

"Unconventional monetary policy, historically large budget deficits, alongside the AI investment boom, appear to be extending the duration of business cycles. The data says the US economy is remarkably strong," The Kobeissi Letter team said.
Meanwhile, the US economy is nearing an impressive achievement on the unemployment front.
The US unemployment rate is nearing a record number of consecutive months below 5%, Truist chief strategist Keith Lerner said in a note on Monday. The longtime record dates back to the mid-1960s.

#letter #consecutive

The Princess of Wales is always poised, elegant and professional during her royal engagements, and she kept her composure even when subtly asking the press to step backwards as she walked by amid an engagement in Norfolk.
It was in June 2020, when COVID-19 restrictions were still in place, that Kate, who was then the ***** ss of Cambridge, made her first face-to-face public engagement since lockdown began. The royal visited Fakenham Garden Centre near her country home, Anmer Hall, and she was seen holding her hands up to distance herself from the press amid the 'two-meter rule'.
Kate adhered to the two metre rule implemented by the UK government (@ Photo: Getty Images)
She could be heard saying: "Hello, how are you? This is two meters," as she moved slightly away from them and stretched out her hands. She then headed to greet employees of the centre, again at a safe distance.
During the visit, Kate shared that her children, Prince George, Princess Charlotte, and Prince Louis, all love visiting garden centres. She also highlighted their enthusiasm for gardening at home, revealing that George enjoys playing with Venus flytraps and that all three children were thrilled to grow tomato plants from seeds, and they grew as tall as the young royals themselves.

#prince #press

Alex Dougherty has said, "Social media saved me."
He's the oldest of 11 kids and part of one of the most popular families on the internet, known as the Dougherty Dozen by their 7.8 million TikTok followers.
Like many people, his mom, Alicia, joined TikTok during the COVID-19 pandemic. She began posting about their extra-large family in 2020, when Alex was 14.
The appeal is simple: Viewers want to see what raising so many children is like, from the everyday to the extraordinary challenges. Seven of the Dougherty kids are adopted, and six have been diagnosed with fetal alcohol spectrum disorders (FASD). Over time, viewers have gotten to know each kid as they grow up.

#like

If you are looking for reliable high yields in the energy sector, Energy Transfer (NYSE: ET) is likely to be high up on the list of options. And Wall Street really likes the stock, with 19 of the 21 ***** ysts covering it rating it a buy or strong buy. And yet, I just can't get myself to buy it, instead owning lower-yielding Enbridge (NYSE: ENB). Here's why Energy Transfer's 6.3% yield, despite distribution coverage of 2.2x, isn't enough to get me to buy it.
Before getting to Energy Transfer, I want to highlight some facts about Enbridge, the North American pipeline giant I actually bought. For starters, Enbridge's yield is 5.8%, roughly half a percentage point lower. That's a big difference, as buying Energy Transfer would increase my income stream by nearly 9%.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
I can totally understand where a dividend investor would buy Energy Transfer for the added yield. But there's a big difference when you consider dividend history. Enbridge has increased its dividend annually for 31 consecutive years. Energy Transfer cut its distribution in 2020 during the COVID pandemic, right when most investors would probably have preferred dividend consistency. To Energy Transfer's credit, it lived up to its promise at the time to reduce leverage and return to distribution growth. In fact, the distribution is now above its level prior to the cut. And the cut was probably the right decision to make for the business.
But that distribution cut was a hit for unitholders. And it comes after another questionable situation back during the 1996 energy market downturn. At that point, Energy Transfer agreed to buy peer Williams (NYSE: WMB), but got cold feet. In an effort to scuttle the deal, Energy Transfer issued convertibles that appeared to protect insiders from a dividend cut, if one were made. The Williams deal was canceled, and the convertibles never became an issue, but it raised material trust issues for me.

#distribution #Dividend #yield

BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial in patients with metastatic squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy. Reuters said gotistobart nearly doubled survival compared with standard-of-care chemotherapy, strengthening the case for the drug as a potential chemotherapy-free treatment in a population with significant unmet need.
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ****** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.

#stage #survival

BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial in patients with metastatic squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy. Reuters said gotistobart nearly doubled survival compared with standard-of-care chemotherapy, strengthening the case for the drug as a potential chemotherapy-free treatment in a population with significant unmet need.
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ***** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.

#biontech #survival

The Justice Department has charged dozens of people for suspected fraud related to the COVID-19 pandemic that resulted in hundreds of millions of dollars in losses, U.S. Attorney General Todd Blanche said Tuesday.
Speaking with reporters in the White House Rose Garden, Blanche said that between mid-June and September, federal prosecutors from across the country helped facilitate the arrests of 160 criminal defendants, including around 80 who were newly charged over suspected COVID fraud in Missouri and neighboring states.
The suspected crimes involved more than $245 million in losses, Blanche said.
White House Launches Interactive Map Tracking Billions In Suspected Fraud
Attorney General Todd Blanche has announced charges against dozens of people connected to suspected COVID-19 relief fraud.

#white #House

In the early 2000s, house-flipping was the get-rich-quick trend that seemingly everyone with enough liquidity wanted to try their hand at. It was popularized by TV shows like Flip This House that showcased fixer-upper success stories and took viewers along for the ride.
Though the heyday ended with the 2008 housing crash, the practice was revived in the COVID-era housing lull and remains popular even now, despite not being as profitable as it once was given rising real estate, material, and labour costs. One way around those realities is to take advantage of the speculative nature of certain properties so a flip doesn't have to involve much renovation work (or any at all, if you're lucky).
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake. Here's what it is and 3 simple steps to fix it ASAP
The tax breaks in Trump's 'big beautiful bill' expire after 2028. Here are 4 moves to make before the window closes

#like #covid #bezos

Kansas City, Missouri — Vice President JD Vance announced Monday the Trump administration will suspend roughly 870,000 people suspected of defrauding pandemic-era small business programs from receiving future federal loans.
The vice president contended that borrowers who stole taxpayer money should no longer be eligible to receive loans from government-backed programs.
"If you screwed the American taxpayer, the federal government is now going to say you're cut off, no more," Vance told reporters. "You shouldn't be applying anymore, and if you do apply, you're no longer able to get those benefits."
His remarks came as the Justice Department announced a slew of cases in a nationwide crackdown on fraud involving the COVID-19-era Paycheck Protection Program.
The department's enforcement push, which ran from June 12 through Sept. 1 and was dubbed "Heartland fraud surge," resulted in actions involving more than 160 defendants and approximately $245 million in intended losses to taxpayers. The operation was put into action more than five years after the government pushed emergency loans to businesses nationwide that were struggling as a result of the coronavirus pandemic.

#president #pandemic #federal

October WTI crude oil (CLV26) on Friday closed down -2.43 (-2.37%), and October RBOB gasoline (RBV26) closed down -0.0860 (-2.53%).
Oct WTI oil prices on Friday fell back after Thursday's +6.7% rally to a 3.5-month high. Oil prices fell back after the International Energy Agency (IEA) on Friday warned that high oil prices and restricted oil supply will cause the biggest drop in global oil demand this year since the Covid-19 pandemic. Despite the projected demand drop, the IEA raised its estimate for this year's global oil deficit to 1.7 million bpd from last month's 1.3 million bpd estimate due to the restricted supply caused by the US-Iran war. The IEA said the return of a global oil surplus will be delayed until 2027, later than its previous estimate of late 2026.
Crude Oil Prices Soar on Fears US-Iran War to Persist
Crude Oil at $100 Gets All the Attention. Watch These 5 Charts to Track the Energy Market Mechanics Behind the Headlines.
Nat-Gas Prices Recover as European Nat-Gas Surges

#prices #estimate #october #closed

The economy, inflation and how those forces could impact the lives of Americans were front and center over the past week. Trips to the grocery store and gas station are more painful than they were last year, and rising costs are impacting the decisions of both households and businesses.
Here's a snapshot of prominent economic data and news that occurred over the past week and what it potentially means for you.
U.S. inflation accelerated last month as gas prices spiked in the wake of renewed fighting in the Middle East, underscoring the affordability challenges that are top of mind for many voters as midterm elections near.
The Labor Department said Friday that the consumer price index rose 3.4% last month compared with a year ago, the same as in July. But on a monthly basis, inflation accelerated, as costs jumped 0.4% from July to August, up from an increase of just 0.1% the previous month.
The figures show that inflation remains stubbornly elevated, more than five years after prices first soared as the economy emerged from the COVID pandemic. Persistent inflation has presented a major challenge for the inflation-fighters at the Federal Reserve and has soured many voters on the Trump administration's economic management.

#year

Gennaro Gattuso is proud of his Lazio side after their 2-2 draw with Milan, claiming that "seeing the team not give up pleases me," as he comments that the empty Stadio Olimpico makes it "feel like the COVID period" as Biancocelesti fans continue to protest against owner Claudio Lotito.
The Aquile thought that they were on track for the perfect start to the Serie A season, as they were leading 2-0 at half-time through Matteo Cancellieri and Tijjani Noslin goals.
Speaking to DAZN, via TuttoMercatoWeb, Gennaro Gattuso was left frustrated but not despondent by the collapse. It would've been four wins out of four, but Diego Moreira came off the bench and scored twice in 120 seconds to get Milan back on track.
"In the second half, they came out with their quality," Gattuso said. "Playing the way we want to play for 90 minutes is hard, we dropped deep at the start of the second half and we struggled. That is also understandable because we conceded two goals I would describe as wonder strikes. We were also good not to get hammered, the feeling was that we could have conceded another two."
Lazio have never in their history started with four consecutive Serie A victories, and that record won't happen this season either, as Milan came back for the 2-2 result. Gattuso, though, took encouragement from how his players reacted to letting a two-goal lead slip.

#four #track #start

Arsenal may have just won the Premier League and reached the final of the Champions League, which means the club has been making significant amounts of money in recent campaigns.
However, the Gunners are also keen to ensure that they have their house in order financially, and the club has reportedly employed BCG to audit its finances in a bid to cut out waste.
Arsenal are one of the clubs that laid off staff during the COVID pandemic, and they also sacked their scouts and reorganised that part of the club despite the many successes it had achieved previously.
They came under significant criticism for that decision, and the Gunners will continue to do what they can to ensure the team remains the main focus of their operations.
The Daily Mail reports that BCG managing director Jean Paul Petranca is leading the review, and it has caused staff to become annoyed and shocked.

#club #arsenal #significant #staff

Florida basketball senior guard Denzel Aberdeen is taking his case to return to the basketball court to the judicial courts.
Aberdeen has filed a temporary injunction for a fifth season of eligibility to play for the Florida Gators, according to a report from the Field of 68.
"Denzel Aberdeen, a senior at Florida, should be allowed to compete as a student-athlete under the NCAA's 5-in-5 rule," Aberdeen's attorney, Jesse Panuccio, said in a statement provided to the Field of 68. "But the NCAA has announced an unwritten exception to its rule that strips Class of 2022 students from this policy, even though they competed for years against fifth-, sixth-, and sometimes seventh-year seniors who received Covid-era eligibility waivers. The NCAA's decision violates its contractual commitment to fairness to all student-athletes, and we have sued to vindicate Aberdeen's rights and get him back on the court as he finishes his degree at UF."
As a member of the Class of 2022, Aberdeen wasn't grandfathered into the NCAA's new 5-for-5 rule, which allows for college athletes to play for five seasons within five years of eligibility.
On July 31, a Colorado court ruling by U.S. District Court judge Charlotte Sweeney (Tyson, Wisne v NCAA) granted an extra year of eligibility to Aberdeen and every athlete in the 2022 class without requiring an NCAA waiver. But on August 22, the 10th Circuit Court of Appeals granted a stay in the Wisne ruling, which now places the onus back on athletes to fight for their NCAA eligibility in state courts.

#class

BVB has never lost a competitive match against SC Paderborn: There have been two DFB-Pokal clashes, both of which saw the Black and Yellows advance to the next round. In the Bundesliga, Borussia has won two matches so far, with two others ending in draws. The most memorable encounter to date was the last Bundesliga match between the two sides at the end of May 2020. In that COVID-19-related match played behind closed doors in Paderborn, the Black and Yellows had a weak first half but stepped up their game after the break. All seven goals in the 6-1 victory came in the second half. Jadon Sancho (3), Thorgan Hazard, Achraf Hakimi, and Marcel Schmelzer—scoring his final professional goal—found the back of the net for BVB.
Best Start in Four Years With six points from two games, BVB has made its strongest start to the season in four years.
Sharp-shooting forwardSerhou Guirassy got on the scoresheet in Sinsheim with the goal that made it 1–2. The forward has been involved in three of BVB's five Bundesliga goals this season and has scored in four consecutive matches across both seasons.
Paderborn, a newly promoted team struggling to find its footing, arrives at SIGNAL IDUNA PARK with one point and still no goals scored. That said, the East Westphalians have already registered 23 shots on goal.
Milestone Within ReachBVB has achieved three wins to start the Bundesliga season only four times in its history (most recently in 2015–16). Now this milestone is once again within reach for the Black and Yellows.

#yellows #match #goals #goal

Amy Sussman / Getty Images, Icon Sportswire / Getty Images
Michael Buckner / Getty Images
Related: "23 Celebs Who Have Admitted To Using Ozempic Or Other Weight Loss Medication"
Shailene hasn't commented much on the relationship or the breakup, previously noting that talking about it "always" made her cry.
Meanwhile, Aaron publicly thanked Shailene for their time together in the wake of the split, while later apologizing to her for the backlash she faced over his divisive comments about the COVID-19 vaccine.

#getty #michael

Tennis star Jessica Pegula and businessman Taylor Gahagen have been together for over a decade
The couple wed in 2021 after a postponement due to COVID-19
Gahagen is the vice president of Pegula's skincare brand, Ready 24
Jessica Pegula's No. 1 fan is her husband, Taylor Gahagen.
Pegula, who is the daughter of Buffalo Bills owners Terry and Kim Pegula, and Gahagen first sparked romance rumors in 2015. While little is known about the early days of their relationship, Gahagen worked for Pegula's parents' sports and entertainment management company for nearly a decade.

#covid

CVS Health (NYSE: CVS) dealt with significant headwinds after the COVID-19 pandemic. The company's financial results suffered as sales of coronavirus-related products (such as diagnostic tests) declined, while expenses in its insurance business rose substantially, resulting in lower profits and margins. However, CVS Health has done a good job of addressing those problems, and the stock has rebounded. Shares are up 31% over the past 12 months. Wall Street thinks there may be even more upside on the horizon. CVS Health's average price target is $116.04 (according to Yahoo! Finance), implying a meaningful 20% upside from current levels. Is now a great time to buy the stock?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Over the past 18 months (or so), CVS Health has implemented several initiatives that have helped improve its business. For instance, the company closed dozens of stores, many of which were unprofitable. The pharmacy chain specialist also scaled back its insurance division, notably by exiting the Affordable Care Act marketplace. The results have been pretty impressive. Consider the company's second-quarter results. CVS Health's revenue increased by a healthy 7.3% year over year to $106.1 billion.
Adjusted earnings per share were $2.58, 42.5% higher than the year-ago period. Note the improvement in CVS Health's healthcare benefits segment, which offers health insurance services. Operating expenses as a percentage of revenue declined slightly to 12.4%, down from 12.5% in the prior-year quarter, even as revenue grew 3.5% year over year. And operating margins within this unit came in at 5.8%, up from the 2.8% reported in the year-ago period. Also, CVS Health's medical benefits ratio -- the percentage of insurance premiums the company spent on medical care (the lower the better) -- declined to 87.4% in the second quarter, down from 89.9% in Q2 2025.
CVS Health also increased its guidance for the full fiscal year 2026. The company now expects its adjusted EPS to fall between $7.90 and $8.10, up from its previous range of between $7.30 to $7.50. The company is also now projecting cash flow from operations of at least $11.5 billion, up from the previous lower bound of $9.5 billion. These are signs of a much-improved business.

#insurance

Wells Adams shared on the 'Off the Vine' podcast with Kaitlyn Bristowe that he and wife Sarah Hyland do little things to keep things romantic, including leaving hidden notes for each other
Adams says cooking for Hyland, including her favorite skirt steak tacos, is one of his romantic gestures
The couple tied the knot in 2022 after postponing their wedding due to the COVID-19 pandemic
Wells Adams knows what it takes to keep his marriage with Sarah Hyland strong.
The TV personality, 42, opened up on the Tuesday, Sept. 8 episode of the Off the Vine podcast with Kaitlyn Bristowe about how he and his wife keep the romance alive, especially when they're spending time apart.

#wells #podcast

If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying replacements for older drugs losing exclusivity. Zoetis is cutting its effective price to keep the franchises it has. Same bet, two opposite defenses.
Pfizer lifted the midpoint of its 2026 revenue guidance by $500 million while cutting its COVID-19 revenue expectation to about $4 billion from about $5 billion. The rest of the company covered that gap: excluding COVID products, the underlying business grew 5% operationally in the second quarter of 2026, with Eliquis and Padcev among the drivers management named.
Zoetis cut its 2026 outlook and now expects revenue to decline 1% to 3% on an organic operational basis. Management said sales trends through July had not yet indicated market stabilization. Pfizer's raise rests on business it can already see. Zoetis has yet to see visibility on market stabilization.
Pfizer is buying growth and cutting cost, and expects about $9.7 billion in total net savings through 2029. What that funds is an aim, not a guide: a risk-adjusted high single-digit revenue CAGR from year-end 2028 through year-end 2033.
The pipeline behind that aim is expensive to get wrong. A Phase III lung cancer trial that missed its primary endpoint and, to a lesser extent, the removal of revenue projections for Oxbryta led to $4.3 billion of noncash intangible **** et impairments recorded in the second quarter of 2026. While an unadjusted price-to-EBIT comparison puts Pfizer at 23.9 against Zoetis at 9.2, aligning the two on operating income brings them to 9.7x and 9.0x, largely erasing the paying-up premium.

#pfizer #covid

To say Pittsburgh Steelers quarterback Aaron Rodgers is a little outspoken would be like saying the Chernobyl disaster was a minor inconvenience. The four-time MVP isn't afraid to share his opinions, and he let loose in the most recent episode of Not Just Football with Cam Heyward.
The episode wasted no time getting into Rodgers' thoughts on why he believes he's so polarizing, to which he called out "hypocrisy" in the media.
"Everybody loved hearing my takes on Colin Kaepernick when I said he was one of the top 64 quarterbacks in the league," Rodgers said. "They loved my takes when there was a shooting that occurred years and years ago during Obama's presidency. Somebody yelled out some anti-muslim rhetoric during the moment of silence, which I thought was so disrespectful. And I said after the game, the first thing I said was, 'There's no place for that kind of hate in this world. Regardless of what happened [or] what you think happened.'… I said something about that and President Obama sent me a hand-written note afterward. And everybody loved that part. They enjoyed my takes. Mina Kimes had me to her house for a feature I did. All of these people were my friends in the media. Until I came about against COVID."
It's not exactly disputable that Rodgers gets no benefit of the doubt from the media after being a genuine media favorite for a long time. To tie it back to his vaccination status is probably pretty on point.
Let us know what you think in the comments. Be sure to bookmark Behind the Steel Curtain for all the latest news, breakdowns, and more!

#Media #years #think

Jeff Klingelhofer, CFA, Managing Director, Portfolio Manager & Senior Research **** yst, Securitized **** ets at Aristotle Pacific didn't set out to be a bond guy but a launchpad at PIMCO, stops in Tokyo and London, and a Chicago MBA detour into a scrappy five-person hedge fund rewired how he thinks about fixed income. The internship stuck, with Klingelhofer building out Thornburg's taxable fixed income desk from employee #3 to Head of Investments, before joining Aristotle Pacific in 2024. The firm is a 15-year-old franchise (formerly Pacific **** et Management) now running roughly $16 billion and, as of July 30, three brand-new ETFs: the Aristotle Core Plus Income ETF (ARCP), the Aristotle Multi-Sector Income ETF (ARMS), and the Aristotle Short Term Income ETF (SDUR).
The pitch isn't about taking on more risk to boost returns but about capturing returns with minimal risk, and that means shopping across every fixed income silo instead of hunting inside one. Klingelhofer gives the example of February 2020, when American Airlines' corporate bond and its aircraft-backed EETC both priced at 3.75% with the same issuer, same tenor, same yield. A month later, COVID hit and the corporate bond cratered to 27 cents on the dollar while the EETC held at 65 cents. Same company, wildly different outcomes because Wall Street desks looked at each instrument in isolation instead of comparing across the capital stack. That's the whole Aristotle Pacific thesis, and it's why he sees the same mispricing setting up today in data center financing.
The three funds slot into that framework by risk level, with SDUR as a low-duration, active-credit alternative to cash, ARCP as a core-bond upgrade aiming to beat the Agg by 100-150bps, and ARMS as the full relative-value expression targeting 250bps over a cycle with real flexibility to shift credit quality. Macro-wise, Klingelhofer thinks the market is underestimating new Fed Chair Warsh, who, unlike his predecessor, inherits a purely high-inflation world with no disinflationary tailwind. It means the firm is positioning the funds slightly long duration as a hedge against credit risk elsewhere in the book. His closing advice to advisors was a cautionary and practical one, that they shouldn't expect Aristotle to work in every environment (no fund does), and to pair its bottom-up process with top-down managers like PIMCO so the two zig and zag differently throughout market cycles.
To learn more about Aristotle Pacific, go here, or you can learn more about their new ETFs here.

#pacific #same #fixed

Tickets: Available via safc.com.
TV/Stream: Full live match coverage is available on Sky Sports+.
Radio: Full live match commentary available via BBC Radio Newcastle (not online)
Don't forget to follow the blow-by-blow account of the game on the Roker Report Twitter feed (RokerReport) and check out the player ratings after the full-time whistle at www.RokerReport.sbnation.c...
We last took on Hull City in the early rounds of the League Cup back in 2020. Back then it was the opening day of the season and behind closed doors due to COVID restrictions. It was also two League One sides slugging it out to see who might be one of the big boys for a payday; now we meet as two Premier League sides.

#match #blow